Sort by
Refine Your Search
-
Starting Date 1 Jan 2026 Is the job funded through the EU Research Framework Programme? Horizon Europe - MSCA Marie Curie Grant Agreement Number 101227453 Is the Job related to staff position within a
-
Fixed-term: The funds for this post are available for 3 years. A doctoral studentship is available in the forthcoming Aspirational Computing Lab (February 2026) in the Department of Computer
-
application of computational tools for the early detection and deconstruction of chromosomal instability in cancer” For further information about the research group, including their most recent publications
-
Two fully-funded 3-year PhD studentships are available in Neuromorphic and Bio-inspired computing at the interface between control engineering, electrical engineering, computational neuroscience
-
, Su J, Eldridge MD, Riedel A, Serrao E, Rodewald HR, Mack M, Shields J, Cohen ES, McKenzie ANJ, Goodwin RJA, Brindle K, Marioni JC, Halim TY. (2020) ILC2-driven innate immune checkpoint mechanism
-
The UKRI-funded 5-year project, 'Colombo: Layered Histories in the Global South City', selected for funding by the European Research Council under its 'HORIZON' programme, is recruiting to its
-
technologies, bulk and single-cell RNA-sequencing, flow cytometry, multiplex immunofluorescence, and standard molecular biology and biochemistry techniques. A computational component may also be available
-
to identify post-translational modifications (PTMs) on FOXA1 that are critical for its ability to cause tumour growth and metastasis, with the goal of finding novel ways of therapeutically blocking FOXA1
-
transcriptomics and histone mark profiling as well as by live imaging approaches. As part of this project, you will have the opportunity to gain computational data analysis skills. This studentship comes with
-
Supervisors: Professor Sir Steve Jackson and Dr Mark O'Connor (AZ Partner) Course start date: 1st October 2026 Project details Targeted Alpha Therapy (TAT) selectively delivers high Linear Energy Transfer (LET) alpha-particles to cancer cells, maximising efficacy while minimising toxicity. ...